❭ Dissertations ❭

Dissertations

Name Title of thesis Year
Amjad Iqbal Hussain Decision-making in patients with severe aortic valve stenosis referred for evaluation of aortic valve replacement 2019
Andreas Auensen Prognostic factors and outcomes in patients with severe aortic stenosis referred for evaluation of possible surgical aortic valve replacement 2018
Kaspar Broch Dilated Cardiomyopathy: Diagnostic Work-up, Pathogenesis, Prognosis and Treatment 2016
Kari Nytrøen Chronotropic responses and effect of high intensity interval based aerobic exercise in heart transplant recipients 2014
Einar Gude Limitations of current treatment strategies in human heart transplantation: Studies on pulmonary hemodynamics, renal failure and immunosuppression 2013
Jan Otto Beitnes Cell therapy in acute myocardial infarction 2012
Christen Peder Dahl Inflammatory cytokines in heart failure – Potential role as mediators and biomarkers 2010
Satish Arora Immunological and non-immunological markers of cardiac allograft vasculopathy amongst heart transplant recipient 2010

 

 
Scroll to top

Home Inflammatory and immunological factors in cardiovascular disease

  • Group members
  • Projects
  • News
  • Publications
  • Collaborators
  • Dissertations

Recent publications

Nendl A, Raju SC, Braadland PR, Nordborg A, Bratseth V, Broch K, Jørgensen SF, Aukrust P, Kristiansen K, Hov JR, Trøseid M, Awoyemi A (2025)
Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis
PLoS One, 20 (9), e0331692
DOI 10.1371/journal.pone.0331692, PubMed 40920777

Karim SR, Jensen NM, Holck EN, Clemmesen TS, Christiansen EH, Jakobsen L, Chen Z, Sonka M, Karason K, Broch K, Solberg OG, Eiskjær H (2025)
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients
J Heart Lung Transplant (in press)
DOI 10.1016/j.healun.2025.07.037, PubMed 40846112

Holmen S, Manintveld O, Damman K, Braun O, Löfman IH, Szymanski M, Ravnestad H, Gude E, Bjørkelund E, Andreassen AK, Gullestad L, Broch K (2025)
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Am Heart J (in press)
DOI 10.1016/j.ahj.2025.08.010, PubMed 40840822

More publications